Friday, 15 Feb 2019

You are here

Dr. Len Calabrese - EULAR 2018 Vasculitis Update on C5a Receptor Inhibitor

EULAR studies on avacopan (CCX168), an oral selective C5a receptor inhibitor

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Rachel Tate: Exhibit Hall

07 Nov 2017

Dr. John Goldman: Autoantibodies

23 Oct 2018

Drs. Arthur Kavanaugh, Doug White and...

30 Oct 2018

Psoriatic Arthritis and the Elevated...

15 Jan 2019

RheumNow Podcast – A Grand New Year (1....

04 Jan 2019

Dr. Ronan Kavanagh: The greatest...

14 Nov 2016

Dr. Naomi Schlesinger - Complete...

15 Jun 2017

Dr. Olga Petryna: Active RA with Normal...

15 Dec 2016

Dr. Brittany Ahmed: Epidemiology of RA...

21 Oct 2018

The RheumNow Week in Review –...

18 May 2018

The RheumNow Week in Review – Cocoon...

20 Jul 2018

Dr. Naomi Schlesinger with Dr. Mohammed...

01 Nov 2018